Medizinische Universität Graz - Research portal
Godschachner Theresa Marie |
Presentations at scientific and public conferences
Leithner, A; Scheipl, S; Smolle, MA; Igrec, J; Szkandera, J; Godschachner, TM; Tiesenhausen, K; Liegl-Atzwanger, B
Ein Unglück kommt selten allein.
Weichteilsarkom Kasuistiken; APR 4, 2025; Salzburg, AUSTRIA. 2025.
[Oral Communication]
Henzinger, H; Brcic, I; Igrec, Jasminka; Godschachner, TM; Scheipl, S; Szkandera, J; Jurmeister, P; Liegl-Atzwanger, B
The role of methylation analysis in distinguishing cellular myxoma from low-grade myxofibrosarcoma
7th Pannonia Congress of Pathology / ÖGPath spring meeting; MAR 7-9, 2024; Vienna, AUSTRIA;. 2024.
[Poster]
Milosevic, I; Speicher, I; Godschachner, T; Viertler, C; Brcic, I; Scheipl, S; Igrec, J; Liegl Atzwanger, B.
Case report of a metastasized GLI1 amplified Sarcoma in a 13 year old patient
ÖGPath Herbsttagung Feldkirch 2024; SEP 26-28, 2024; Feldkirch, Österreich. 2024.
[Poster]
Godschachner, TM; Igrec, J; Kratchowill, N; Jurmeister, P;
Liegl Atzwanger, B;Brcic, I
Genetic/epigenetic characterization of benign osteogenic bone tumors and their correlation with clinicopathological and radiological findings.
.. 2023; -ÖGPath Herbsttagung 2023; Sept 28-30, 2023; Innsbruck.
[Poster]
Godschachner, TM; Beham-Schmid C
Fallpräsentation Plasmazellmyelom
ÖGPath Herbsttagung 2022; Sept 22-24, 2022; Bad Ischl, AUSTRIA. 2022.
[Oral Communication]
Godschachner, TM; Igrec, J; Scheipl, S; Leithner, A; Liegl-Atzwanger, B; Brcic, I
Usefulness of novel SS18-SSX and SSX c-terminus antibodies for identification of specific fusion oncoprotein in sarcomas
VIRCHOWS ARCH. 2022; 481(SUPPL 1): S121-S121.
[Poster]
Web of Science
FullText
Krall, A; Matejka, J; Godschachner, T; Posch, A; Stauber, RE
Comparison of CRAFITY and PROSASH-II for prediction of survival in patients with hepatocellular carcinoma treated with sorafenib.
. 2022; -55. Jahrestagung & 32. Fortbildungskurs ÖGGH; SEP 7-9, 2022; Vienna, AUSTRIA.
[Poster]
Brcic, I; Godschachner, TM; Bergovec, M; Igrec, J; Scheipl, S; Kashofer, K; Leithner, A; Szkandera, J; Liegl-Atzwanger, B
Use of pant-TRK immunohistochemistry for identification of NTRK fusions in mesenchymal neoplasms - real life experience.
Virchows Archiv. 2020; 477(1):S19--32nd Congress of the ESP and XXXIII International Congress of the IAP; DEZ 5-9, 2020; Glasgow.
[Onlinepräsentation]
Godschachner, T; Rainer, F; Sarocchi, F; Wackernagel, W; Kump, P; Brcic, I
Cerebral metastasis of a large cell neuroendocrine carcinoma in a patient with an atypical neuroendocrine tumor of the lung
24. Jahrestagung der ÖGES gemeinsam mit der Österreichischen Schilddrüsengesellschaft und der Austrian Neuroendocrine Tumor Society; APR, 24-26, 2019; Graz, AUSTRIA. 2019.
[Poster]
Schulte, J; Attanoos, R; Brcic, L; Butnor, K; Chapel, D; Dacic, S; Fukuoka, J; Salle, FG; Godschachner, T; Hiroshima, K; Klebe, S; Krausz, T; Litzky, L; Marchevsky, A; Mueller, J; Nicholson, A; Roden, A; Santoni-Rugiu, E; Tazelaar, H; Walts, A; Weynand, B; Zhang, YZ; Husain, A
Biopsy Accurately Predicts Resection Pathologic Parameters in Malignant Mesothelioma: A Multi-Institutional Analysis.
LAB INVEST. 2019; 99: -108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity; MAR 16-21, 2019; National Harbor, MD, USA.
[Poster]
Web of Science
Schulte, J; Attanoos, R; Brcic, L; Butnor, K; Chapel, D; Dacic, S; Fukuoka, J; Salle, FG; Godschachner, T; Hiroshima, K; Klebe, S; Krausz, T; Litzky, L; Marchevsky, A; Mueller, J; Nicholson, A; Roden, A; Santoni-Rugiu, E; Tazelaar, H; Walts, A; Weynand, B; Zhang, YZ; Husain, A
Biopsy Accurately Predicts Resection Pathologic Parameters in Malignant Mesothelioma: A Multi-Institutional Analysis.
MODERN PATHOL. 2019; 32: -108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity; MAR 16-21, 2019; National Harbor, MD, USA.
[Poster]
Web of Science